Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01048853 · ClinicalTrials.gov registry record · NA
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer
A NA study, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT01048853: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT01048853 is a NA study that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 137 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01048853, a NA study, was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
This clinical trial studies conservative surgery in treating patients with low-risk stage IA2 or IB1 cervical cancer. Conservative surgery is a less invasive type of surgery for early stage cervical cancer and may have fewer side effects and improve recovery.
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Therapeutic Conventional Surgery
- PROCEDURE Sentinel Lymph Node Biopsy
- PROCEDURE Lymph Node Mapping
- PROCEDURE Salpingo-Oophorectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2010-04-15 |
| Est. Completion | 2025-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01048853
The ClinicalTrials.gov registry entry for NCT01048853 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01048853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01048853 about?
NCT01048853 is a clinical study titled "Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer". This clinical trial studies conservative surgery in treating patients with low-risk stage IA2 or IB1 cervical cancer. Conservative surgery is a less invasive type of surgery for early stage cervical cancer and may have fewer side effects and improve recovery.
What is the current status of trial NCT01048853?
This trial is currently terminated. It is a NA study. The enrollment target is 137 participants. The study started on 2010-04-15. Estimated completion is 2025-12-05.
What interventions are being tested in trial NCT01048853?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Therapeutic Conventional Surgery (PROCEDURE), Sentinel Lymph Node Biopsy (PROCEDURE), Lymph Node Mapping (PROCEDURE), Salpingo-Oophorectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01048853?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.